The incidence of other main drugs for HF was similar in both groups: angiotensin‐converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs) (86.6% vs. 89.3%, p = 0.202), beta‐blockers (BB) (93.6% in both groups, p = 1.000), or mineralocorticoid receptor antagonists (MRA) (68.0 vs. 63.9, p = 0.184). The gene discussed is NR3C2; the disease is hydrops fetalis.